Analystreport

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) had its price target raised by analysts at Aegis from $20.00 to $35.00. They now have a "buy" rating on the stock.

Oramed Pharmaceuticals Inc.  (ORMP) 
Last oramed pharmaceuticals inc. earnings: 4/6 04:46 pm Check Earnings Report
US:NASDAQ Investor Relations: oramed.com/investors